Overview

Use of Rosiglitazone in the Treatment of Endometriosis

Status:
Terminated
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to perform a pilot study on the efficacy of rosiglitazone in reducing pelvic pain in early stage endometriosis patients.
Phase:
Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator:
Berlex Foundation
Treatments:
Rosiglitazone